Doctors Split on Pharmaceutical Marketing Influence
Doctors weigh benefits of pharma marketing while warning it risks patient trust.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Doctors weigh benefits of pharma marketing while warning it risks patient trust.
Whistleblowers accuse Meta of hiding child safety risks as Congress investigates.
Study reveals thousands of uncounted opioid deaths, raising concerns about treatment funding.
Texas lawmakers remain divided on hemp-derived THC rules, leaving businesses and consumers uncertain.
WHO adds cancer, diabetes, and obesity drugs to global essential medicines lists.
City council approves legal case over homeless encampment on private property.
Researchers developed a device that automates egg preparation for IVF treatments.
Researchers link chemotherapy treatment to disrupted circadian rhythms affecting sleep and behavior.
The company resolves a federal case over how it improperly labeled children’s videos on YouTube.
Research shows many cancer surgery patients remain on opioids long after recovery.